KERRI COPELAND: Open Payments
NPI 1821562562 · LINDEN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,576 in 101 payments from 22 companies in 2025. Trend: 2023 $1,012 · 2024 $1,127 · 2025 $1,576
Food & beverage: $1,576
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $304 |
| ABBVIE INC. | 25 | $270 |
| Novo Nordisk Inc | 14 | $176 |
| Amgen Inc. | 10 | $173 |
| Abbott Laboratories | 5 | $95 |
| Exact Sciences Corporation | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Corcept Therapeutics | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
Products named: UBRELVY, NURTEC ODT, ELIQUIS, OTEZLA, FREESTYLE LIBRE 3, REXULTI, Ozempic, Rybelsus.
Industry payments across MI — which companies pay providers there.
